<- Go Home

SofWave Medical Ltd.

SofWave Medical Ltd. engages in the development, production, marketing, and distribution of non-invasive medical technology for skin firming and rejuvenation, tissue renewal, treatment of muscle, aging, and other physiological change in Israel, the United States, Europe, Southeast Asia, the Middle East, and internationally. The company offers an ultrasound technology that induces coagulation and subsequent revitalization for regenerated skin under the SUPERB brand; and non-invasive muscle toning technology under the Pure Impact VIP brand. It serves plastic surgeons, dermatologists, and other physicians who perform aesthetic treatments on patients. It also provides technical and clinical product support services. The company was incorporated in 2015 and is based in Yokneam Illit, Israel.

Market Cap

ILS 422.3M

Volume

64.4K

Cash and Equivalents

ILS 28.2M

EBITDA

ILS 11.4M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

ILS 78.6M

Profit Margin

75.33%

52 Week High

ILS 16.26

52 Week Low

ILS 8.07

Dividend

N/A

Price / Book Value

11.13

Price / Earnings

53.21

Price / Tangible Book Value

11.13

Enterprise Value

ILS 385.4M

Enterprise Value / EBITDA

31.58

Operating Income

ILS 10.1M

Return on Equity

27.42%

Return on Assets

11.83

Cash and Short Term Investments

ILS 38.3M

Debt

ILS 1.4M

Equity

ILS 38.0M

Revenue

ILS 104.3M

Unlevered FCF

ILS 13.0M

Sector

Health Care Equipment and Supplies

Category

N/A

Company Stock Pitches